Oct 18, 2016· Comment from Advanced Medical Technology Association (AdvaMed)· FDA-2016-D-1233-0019
Filed on regulations.gov — full text not in the inline record.
FDANonrulemakingFDA-2016-D-1233
Use of Public Human Genetic Variant Databases to Support Clinical Validity for Next Generation Sequencing (NGS)-Based In Vitro Diagnostics; Draft Guidance for Stakeholders and Food and Drug Administration Staff; Availability
RIN
—
Last modified
Apr 17, 2018
Comment window
closed 3582d ago
Advanced Medical Technology Association filings
1
Activity
Advanced Medical Technology Association filed 1 comment on this docket between Oct 18, 2016 and Oct 18, 2016. 15 other organizations filed here. The comment window closed 3582d ago.
What Advanced Medical Technology Association filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (15)
See everyone who commented →- Advanced Medical Technology AssociationTHIS ORG1 filing · confidence 97%
- American Association for Cancer Researchtrade assoc.1 filing · confidence 85%
- American Association for Clinical Chemistrytrade assoc.1 filing · confidence 85%
- American Cancer Society Cancer Action Networktrade assoc.1 filing · confidence 85%
- American Clinical Laboratory Associationtrade assoc.1 filing · confidence 85%
- American Medical Associationtrade assoc.1 filing · confidence 97%
- American Medical Informatics Associationtrade assoc.1 filing · confidence 85%
- American Pharmacists Association (APhA)trade assoc.1 filing · confidence 97%
- American Society of Human Geneticstrade assoc.1 filing · confidence 85%
- Association for Molecular Pathologytrade assoc.1 filing · confidence 85%
- Foundation Medicinetrade assoc.1 filing · confidence 85%
- Global Alliance for Genomics and Healthtrade assoc.1 filing · confidence 85%
- National Society of Genetic Counselorstrade assoc.1 filing · confidence 85%
- Personalized Medicine Coalitiontrade assoc.1 filing · confidence 85%
- Pfizer Inc.unverified attribution1 filing · confidence 70%
- The Coalition for 21st Century Medicinetrade assoc.1 filing · confidence 85%